Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ningbo Huize Commodity is a China-based manufacturer of over-the-counter personal care and consumer health products, including sunscreen, hand sanitizer, lip balm, and related daily-use items. The company appears to operate primarily as a commercial manufacturer rather than an R&D-driven biotech or therapeutics developer. U.S. FDA records show the company manufactured OTC drug products such as sunscreen lotion and was the subject of a 2019 FDA warning letter citing significant CGMP and data integrity violations at its Yuyao, Zhejiang facility. Publicly available product-label information indicates several U.S. NDC-listed products, which are currently inactivated. Overall, this is best characterized as a small commercial OTC/cosmetics manufacturer with some healthcare adjacency, not a biotech pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ningbo Huize Commodity.